CoronaryAtlas logo
CoronaryAtlas
ASCVD Risk Atlas
← Back to table
C

Systolic hypertension

Blood Pressure & HemodynamicsPhysical parameterriskmodifiable
9
evidence score
PREVENT status

Not a PREVENT input variable.

Causal support

trial evidence

Score components
lit volume: 3meta-analyses: 0trials: 6genetic: 0MR bonus:

References (1)

0 meta-analyses / systematic reviews

Clinical trials (3)

NCTTitleStatusTypeInterventions
NCT00353574DORADO-EX - A Dose-Blinded, Long-Term Safety Extension Study of Fixed Doses of Darusentan in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic (Protocol DAR-311-E)TERMINATEDINTERVENTIONALDarusentan
NCT04755764The Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by Impedance Cardiography in Early PregnancyRECRUITINGOBSERVATIONALLabetalol, Atenolol, Nifedipine
NCT03712033TEC4Home Stroke - Assessing the Feasibility of Home Telemonitoring Technology in Managing Hypertension Among Stroke/TIA Patients. Pilot Study at Vancouver Stroke Program in Collaboration With TEC4Home Heart Failure TeamCOMPLETEDOBSERVATIONAL

Genetic associations (0)

None linked.